PLX short interest
Protalix BioTherapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,040,042 |
|---|---|
| Change vs prior report | 162,302 (+5.6%) |
| Change over six months | -35.3% |
| Days to cover | 4.29 (sector: 3.78) |
| Average daily volume | 709,069 |
| Rank in Healthcare | #492 of 922 by days to cover |
PLX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,040,042 | +5.6% | 4.29 | 709,069 |
| 2026-09-15 | 2,877,740 | -9.1% | 3.82 | 754,146 |
| 2026-08-31 | 3,165,145 | -11.5% | 4.75 | 666,406 |
| 2026-08-14 | 3,576,201 | -7.8% | 3.71 | 964,114 |
| 2026-07-31 | 3,878,764 | +4.4% | 7.46 | 520,066 |
| 2026-07-15 | 3,715,907 | +4.4% | 6.56 | 566,413 |
| 2026-06-30 | 3,558,923 | -9.0% | 4.18 | 851,438 |
| 2026-06-15 | 3,910,669 | -0.6% | 7.07 | 552,862 |
| 2026-05-29 | 3,935,161 | -6.0% | 4.93 | 798,578 |
| 2026-05-15 | 4,183,989 | -17.2% | 3.89 | 1,074,212 |
| 2026-04-30 | 5,055,741 | +7.0% | 9.74 | 518,865 |
| 2026-04-15 | 4,726,273 | +0.5% | 6.65 | 710,842 |
| 2026-03-31 | 4,702,042 | +7.4% | 3.91 | 1,203,203 |
| 2026-03-13 | 4,378,823 | +4.9% | 4.50 | 974,144 |
| 2026-02-27 | 4,174,736 | -7.8% | 2.77 | 1,507,696 |
| 2026-02-13 | 4,527,493 | +10.0% | 2.07 | 2,191,884 |
| 2026-01-30 | 4,116,458 | -9.5% | 4.60 | 894,889 |
| 2026-01-15 | 4,550,338 | +8.0% | 4.33 | 1,049,806 |
| 2025-12-31 | 4,211,881 | -4.6% | 6.77 | 622,056 |
| 2025-12-15 | 4,416,360 | +6.2% | 8.55 | 516,654 |
| 2025-11-28 | 4,156,781 | +1.4% | 8.18 | 507,898 |
| 2025-11-14 | 4,100,254 | -1.4% | 6.55 | 625,800 |
| 2025-10-31 | 4,156,466 | -11.7% | 3.62 | 1,147,523 |
| 2025-10-15 | 4,704,650 | +13.3% | 4.64 | 1,014,322 |
| 2025-09-30 | 4,152,594 | +13.4% | 6.08 | 682,507 |
import finzdata as yf
yf.Ticker("PLX").short_interest # every report since 2017
yf.Client().short_interest(["PLX"], start="2018-01-01")Healthcare short interest · PLX price history · Who owns PLX · All short interest